The PIVOT consortium collaborates with industry partners on preclinical testing of molecularly targeted agents developed for adult cancers to evaluate their applicability to the treatment of pediatric cancer.

The Pediatric Preclinical In Vivo Testing (PIVOT) consortium comprises a coordinating center and seven academic research programs specializing in basic research and preclinical testing of treatments for the most common pediatric cancers. Our team has decades of experience with the development, characterization and testing of in vivo models of pediatric cancer. PIVOT is a public-private partnership funded by the National Cancer Institute (NCI).